ONWARD TOGETHER

WIPO WIPO 2016

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ONWARD TOGETHER wurde als Wortmarke am 15.09.2016 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 06. April 2018

Markenform Wortmarke
Aktenzeichen 1340659
Länder Australien Schweiz Europäische Gemeinschaft Indien Südkorea Mexiko Norwegen
Basismarke US Nr. 87166541, 09. September 2016
Anmeldedatum 15. September 2016
Ablaufdatum 18. Juli 2017

Markeninhaber

One Broadway
Cambridge MA 02142
US

Markenvertreter

Fross Zelnick Lehrman & Zissu, P.C., 4 Times Square, 17th Floor US

Waren und Dienstleistungen

09 Software for mobile devices for a diabetes support program that connects patients and caregivers to medical service providers and facilitates the exchange of medical data and medical advice; mobile application for medical and condition support for the treatment of diabetes; mobile application for medical professionals and medical patients featuring information relating to diabetes and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions; mobile application intended for diabetic patients for recording blood test results from a blood glucose monitor; software downloadable via the internet or mobile applications for monitoring and tracking blood glucose levels
10 Medical monitors for the detection, measurement and monitoring of physiological substances relating to diabetes, and parts and components thereof; blood glucose monitors; blood glucose monitors sold as a unit with blood glucose monitoring kits; medical equipment for monitoring diabetes, namely, sensors for measuring blood glucose levels, patient monitoring sensors for biotechnology applications, drug delivery apparatus for measuring dosages and delivering pharmaceuticals, and apparatus for drawing or sampling blood or other bodily fluids; injectable insulin pens sold empty; insulin pumps for medical use sold empty; blood monitoring apparatus
38 Telecommunications; transmission of digital files; transmission of information and images via wireless communication networks regarding healthcare; transmission of information for others in the field of healthcare; transmission of information addressed to patients or healthcare professionals via wireless communication networks; transmission of information and images relating to pharmaceuticals and medicine via all means of telecommunication including the Internet and wireless communication networks; transmission of information via electronic communication networks and wireless communication networks; transmission of information in the field of diabetes; radio broadcasting service; provision of online forums and electronic bulletin boards for the transmission of messages among computer users in the pharmaceutical, medical, and healthcare fields; provision of internet chat rooms
42 Software as a services (SAAS) featuring software for mobile devices for a diabetes support program that connects patients and caregivers to medical service providers and facilitates the exchange of medical data and medical advice; software as a services (SAAS) featuring software for mobile devices for medical professionals and medical patients for purposes of monitoring blood glucose levels and for purposes of facilitating the exchange of medical data and medical advice for the treatment of diabetes; software as a services (SAAS) featuring software for mobile devices for medical professionals and medical patients featuring information relating to diabetes and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions
44 Provision of medical and condition support for the treatment of diabetes, by way of a mobile application; provision of medical information for doctors, patients, and caregivers in the field of diabetes; provision of medical and pharmaceutical information and advice in the field of diabetes; consulting in the field of diabetes; healthcare services provided through disease management programs in the field of diabetes; provision of medical information in the field of healthcare; health care services; medical consultation; medical services provided through disease management programs concerning healthcare; provision of medical information via the Internet; provision of health and pharmaceutical information
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
22. September 2017 2017/41 Gaz NO Ablehnung
17. August 2017 2017/33 Gaz JP Ablehnung
17. August 2017 2018/14 Gaz JP RAW: Second Part Fee Not Paid
02. August 2017 2017/31 Gaz AU Ablehnung
18. Juli 2017 2017/34 Gaz RAW: Total Cancellation
28. Juni 2017 2017/28 Gaz EM Ablehnung
15. September 2016 2017/14 Gaz US Eintragung

ID: 141340659